Search

At least six different Homospecies populated the World during the latest Pliocene to the Pleistocene. The extinction of all but one of them is currently shrouded in mystery, and no consistent explanation has yet been advanced, despite the enormous importance of the matter. Here, we use a recently implemented past climate emulator and an extensive fossil database spanning 2,754 archaeological records to model climatic niche evolution in Homo. We find statistically robust evidence that the three Homospecies representing terminating, independent lineages, H. erectus, H. heidelbergensis, and H. neanderthalensis, lost a significant portion of their climatic niche space just before extinction, with no corresponding reduction in physical range. This reduction coincides with increased vulnerability to climate change. In the case of Neanderthals, the increased extinction risk was probably exacerbated by competition with H. sapiens. This study suggests that climate change was the primary factor in the extinction of Homospecies.

Purpose: Medical imaging applied to archaeological human remains represents a powerful tool for the study of specimens of exceptionally fragile nature. Here, the authors report a tomographic computerized investigation on the naturally mummified human remains from the Takarkori rock shelter (Libyan Sahara), dated to the Middle Pastoral Neolithic (ca. 6100-5600 uncal BP). The paper aims to discuss this issue. Design/methodology/approach: Medical radiological techniques allowed us to discriminate and isolate the tissues preserved thanks to their different electron density, driving us to detailed examinations of features of interest. Findings: With a focus on anatomy and taphonomy, the authors infer on post-depositional phenomena in a way that could not be achieved through traditional approaches. Originality/value: The investigation of digital data allows to acquire new sets of information with no risk for the original object. This case study is especially important considering that the human remains from Takarkori are currently not available to the scientific community due to political instability in Lybia.

ABSTRACTThe remains that typically compose the human fossil record often bear cracks, damage, and deformations. The recent rapid development of ‘virtual anthropology’ has provided innovative tools to manage, study, and preserve cultural and natural heritage. Such tools include computerized tomography (CT), laser scanning, photogrammetry, 3D imaging, and rapid prototyping. These approaches can contribute to any archaeological context from the discovery of artefacts to research, preservation, and dissemination. 3D imaging techniques can substitute physical intervention with a virtual protocol to restore the original shape of a fossil specimen. In a similar way, digital morphological information can be recovered using data preserved even on a fragment through the use of 3D comparative samples. Here we present an extended and updated review of the most innovative protocols in virtual anthropology, also applicable in other fields such as natural history and cultural heritage studies, through the description of recent cast studies.

Healthcare decision makers need to make trade-offs between different elements of value of new treatments. Multicriteria decision analysis (MCDA) provides a framework that can help decision makers to understand stakeholders’ preferences and be explicit about the trade-offs that are being made. The objective of this study was to use MCDA to obtain preferences and views on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and to use these to assess the performance of obinutuzumab for rituximab-refractory indolent non-Hodgkin lymphoma (iNHL). We used EVIDEM V3.0, an MCDA framework, and collected participants’ preferences via an online survey and structured meetings. Patients and clinicians expressed a preference for interventions targeting severe conditions. Payers expressed preference for treatments targeting areas with an unmet need, which are cheaper than the comparator, and with high-quality evidence. Obinutuzumab in combination with bendamustine, compared with bendamustine alone, received high positive scores for the criteria ‘disease severity’ and ‘type of therapeutic benefit’ by all three groups, and negative scores on the economic-related criteria, according to all stakeholder groups. MCDA can be used to elicit the views of different stakeholder groups and has the potential to structure and inform reimbursement decisions.